Donna Ambrosino
Direktor/Vorstandsmitglied bei CLOVER BIOPHARMACEUTICALS, LTD.
Vermögen: 6 925 $ am 30.04.2024
Profil
Donna M.
Ambrosino is a professional with a doctorate degree from Dartmouth Medical School and an undergraduate degree from Harvard University.
She is currently a Non-Executive Director at Clover Biopharmaceuticals Ltd.
since 2022.
Previously, she worked as the Chief Medical Officer at Visterra, Inc. from 2012 to 2014.
She also held the position of Associate Professor at Harvard Medical School.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
15.04.2024 | 156 992 ( 0,01% ) | 6 925 $ | 30.04.2024 |
Aktive Positionen von Donna Ambrosino
Unternehmen | Position | Beginn |
---|---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 17.06.2022 |
Ehemalige bekannte Positionen von Donna Ambrosino
Unternehmen | Position | Ende |
---|---|---|
VISTERRA INC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 |
Harvard Medical School | Corporate Officer/Principal | - |
Ausbildung von Donna Ambrosino
Dartmouth Medical School | Doctorate Degree |
Harvard University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Visterra, Inc.
Visterra, Inc. Pharmaceuticals: MajorHealth Technology Visterra, Inc. Is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of antibody-based therapies for kidney diseases, and other chronic diseases. It focuses on its research technology platform, HIEROTOPE technology. The company was founded by Alan L. Crane, Kevin J. Bitterman and Ram Sasisekharan on December 20, 2007 and is headquartered in Waltham, MA. | Health Technology |